Sulforaphane Supplements Manufacturer

Broccoli Seed Extract vs. Broccoli Sprout Extract vs. Mature Broccoli Extract

KSNutripharma Recommendation

For most commercial sulforaphane supplements, we recommend standardized broccoli seed extract or broccoli sprout extract containing 10–13% glucoraphanin, as these materials provide the best balance of active compound concentration, batch consistency, manufacturing stability, and commercial scalability.

Mature broccoli extract remains a valuable botanical ingredient for whole-food nutrition products, but it is generally not the preferred source for high-potency sulforaphane supplements due to its naturally low glucoraphanin content.

Standardized Glucoraphanin

Glucoraphanin is the most widely used specification for commercial sulforaphane supplements because of its superior stability and manufacturing practicality.

Typical commercial specifications include:

• <0.5% – Mature broccoli extract, primarily used for whole-food nutritional products
• 5% – Entry-level standardized formulations
• 10% – Mainstream commercial specification for broccoli seed or sprout extract
• 13% – Premium industry benchmark widely adopted by science-backed brands
• 20% – Practitioner-grade formulations
• 30%+ – Customized high-potency ingredients

Most commercial OEM projects utilize 10–13% standardized glucoraphanin, offering the best balance between efficacy, stability, and production cost.

Standardized Sulforaphane

Although active sulforaphane can be supplied as a standardized ingredient, it is inherently unstable and significantly more difficult to manufacture than glucoraphanin.

Typical commercial specifications include:

• 0.1–0.5% – Naturally generated sulforaphane
• 1% – Standard activated ingredient
• 2%+ – Specialty material requiring advanced stabilization technologies

For this reason, most commercial supplements are formulated with standardized glucoraphanin together with myrosinase rather than pre-activated sulforaphane, providing better shelf stability while allowing sulforaphane to be generated after consumption.

Myrosinase Activity

Myrosinase is the enzyme responsible for converting glucoraphanin into biologically active sulforaphane. Without sufficient enzyme activity, the conversion efficiency may be significantly reduced.

Typical commercial activity levels include:

• 1,000–5,000 U/g – Entry-level synergistic formulations
• 10,000–30,000 U/g – Mainstream commercial formulations
• 50,000+ U/g – High-activity premium formulations requiring specialized stabilization

Depending on formulation strategy, myrosinase may be supplied as a purified enzyme or naturally retained through carefully processed broccoli sprout powder.

Recommended Specifications by Product Positioning

KSNutripharma Selection Principles

When developing commercial sulforaphane supplements, we recommend evaluating raw materials based on total formulation performance rather than specification alone.

✔ Select standardized glucoraphanin instead of relying solely on extract ratios.

✔ Evaluate the effective glucoraphanin delivered per serving, not just the percentage specification.

✔ Choose the appropriate raw material source (seed, sprout, or mature broccoli) according to your product positioning.

✔ Consider myrosinase activity, stability, and manufacturing feasibility together when selecting formulation strategies.

✔ Request HPLC-verified specifications, stability data, and complete batch traceability before commercialization.

Specification Does Not Equal Daily Intake

A higher specification does not automatically result in a more effective product. The actual amount of glucoraphanin delivered per serving is often more important than the percentage listed in the raw material specifications.

For most commercial formulations, a daily intake of 15–30 mg of standardized glucoraphanin provides a practical balance between efficacy, formulation flexibility, and production cost.

Many sulforaphane supplements lose potency before reaching consumers — and the manufacturer is often the last to know. At KSNutripharma, we have seen brands recall batches, rewrite labels, and lose retail placements because these technical risks were not addressed at the formulation stage. Here are the most common failure points:

Our formulation platform is designed specifically to address these technical risks before they become commercial liabilities. Every project begins with a technical risk assessment, and every batch ships with documented proof that these risks have been controlled.

Understanding this pathway is not optional — it determines every technical decision in your product, from raw material selection to packaging. Here is the complete chain, and where KSNutripharma adds value at each step:

Key procurement insight: Most successful sulforaphane supplements on the market are built on glucoraphanin + myrosinase co-delivery, not pre-activated sulforaphane. The stability advantages of this approach are overwhelming — which is why KSNutripharma recommends it as the default platform for all new projects.

KSNutripharma operates a dedicated sulforaphane production platform — not a general-purpose line adapted for the ingredient. Every step below is optimized specifically for the stability requirements of glucoraphanin, myrosinase, and sulforaphane:

End-to-End Process Flow

Each process step includes defined Critical Process Parameters (CPPs) and in-process control points. Full process validation documentation is available for regulatory submissions and third-party audits.

Manufacturing Capability

Procurement decisions require hard numbers. Here is exactly what KSNutripharma can deliver for your sulforaphane product line:

KSNutripharma applies Quality by Design principles to every sulforaphane project. We define Critical Quality Attributes (CQAs) and Critical Process Parameters (CPPs) at project initiation, ensuring quality is engineered into the product — not tested in at the end.

Critical Quality Attributes (CQAs)

Critical Process Parameters (CPPs)

Risk Assessment & Risk Control

Every sulforaphane manufacturing project at KSNutripharma begins with a formal risk assessment. We identify potential failure modes, evaluate their impact on product quality and patient safety, and implement controls before manufacturing begins.

This risk-based approach is not a one-time exercise. Risk assessments are reviewed and updated at every product revision, complaint investigation, and annual product quality review (APQR).

Standard Batch Documentation

• Certificate of Analysis (COA)— Batch-specific test results for all specification parameters
• Product Specification— Complete quality specification with test methods and acceptance criteria
• Technical Data Sheet (TDS)— Product description, composition, physicochemical properties, handling guidelines
• Material Safety Data Sheet (MSDS)— Safety information, hazard classification, handling precautions, first aid
• Residual Solvent Report— GC-MS analysis confirming compliance with ICH Q3C limits
• Heavy Metal Report— ICP-MS data for Pb, Cd, As, Hg
• Microbiology Report— TAMC, TYMC, specified organism testing per USP <61>, <62>
• Stability Summary— Available stability data with storage conditions and retest period

Regulatory & Compliance Statements

• Allergen Statement— Free from major allergens; customizable per market requirements
• Non-GMO Statement— Available for non-GMO formulations
• BSE/TSE Statement— Free from bovine spongiform encephalopathy / transmissible spongiform encephalopathy risk materials
• Halal Certificate— Available upon request
• Kosher Certificate— Available upon request
• ISO 22000— Certified
• FSSC 22000— Certified
• cGMP Compliance— Per 21 CFR Part 111 (US) and applicable EU regulations

We provide end-to-end packaging services from primary container selection through finished goods kitting and shipment to your designated warehouse or 3PL.

Primary Packaging

• Amber glass bottles (30cc-240cc) with child-resistant caps — ideal for liquid and softgel products
• PET/HDPE bottles with induction seals — cost-effective for capsules and tablets
• Blister packs (PVC/PVDC, aluminum-aluminum) — retail and travel-friendly formats
• Stand-up pouches and single-serve sachets — powder and stick pack products
• Glass dropper bottles (30mL-120mL) — liquid formulations and functional shots

Label & Design Services

• In-house design team with supplement industry expertise
• Regulatory-compliant label review for structure/function claims
• Multi-language label capabilities (English, Spanish, French, German)
• Amazon FBA-compliant labeling and bundling

Secondary Packaging

• Retail cartons with UPC barcodes
• Display-ready case packaging
• Subscription box format optimization

We structure minimum order quantities to support brands at every stage of growth, from market testing to national retail distribution.

Samples & Prototyping

• Pre-formulated samples: Free (shipping cost applies); 5-7 business days
• Custom formula prototype: $500-2,000; 2-3 weeks
• Pilot batch (minimum 100 units): Available for validation testing

Pricing Structure

Unit pricing is determined by order volume, dosage form complexity, and formula customization level. Pre-formulated products offer the most competitive pricing. Custom formulations include a one-time development fee of $500-2,000 depending on complexity and number of prototype iterations required.

Scaling Notes

Lead times assume formula finalization and packaging artwork approval. First-time custom formulations add 2-4 weeks for development and stability screening. Rush production may be available for established formulas — contact your project manager for scheduling.